Yıl: 2017 Cilt: 6 Sayı: 4 Sayfa Aralığı: 629 - 634 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Investigation of the protective and treatment effects of vinpocetine in myocardial infarctional with isoprotenol in rats

Öz:
As aim of this study, the knowledge of whether vinpocetine (VINPO) is cardioprotective or not following isoprotenol (ISO)-induced cardiac ischemia in rats. In myocard infarction, the one of the responsible mechanisms of injury is oxidative damage and inflammmation. The effect of VINPO which is the potent antioxidant and anti inflammatory agent aimed to reveal as the biochemical, electrophysiological, and histopathologic parameters. In this study, thirty- two Wistar-Albino male rats were divided into four groups, each consisting of eight rats. The group 1 named as sham, no any drug used in this group. Group 2 named as iso group, only ISO was adminestered, the group 3 named as VINPO and iso group, here initially vinpocetine then ISO were used, and the group 4 named as iso and VINPO, here initially ISO then VINPO were used. For the rats in group 2, in first and second day ISO adminestered at a dose of 120mg/kg using an intraperitoneal injection. At third and fourth day no any drug used. And at fifth day the experiment terminated. For the rats in group 3, at the first and second day VINPO adminestered at adose of 20 mg/kg using an intraperitoneal (ip) injection, after 30 minute isoprotenol administered at adose of 120 mg/kg using an ip injection. At third and fourth day no any drug was used. And at fifth day experiment was terminated. Lastly for the rats in group4, first and second day ISO administered at a dose of 120 mg/kg using an ip injection, at third and fourth day VINPO adminestered at a dose of 20 mg/kg using an ip injection, and at fifth day experiment terminated. Prior to termination of experiment the pulse rate and ECG changes were recorded. After completion of experiment protocols blood samples and cardiac tissue samples were recieved. For the knowledge of effects of VINPO experimental miyocardial ischemia induced in rats, and the serum myoglobulin, total creatine kinase (CK), lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanin aminotransferase (ALT), measured. In myocardial tissue as an antioxidative system and an oxidative stres markers; malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathine (GSH), total oxidant status (TOS), total antioxidant status (TAS), oxidative stres index (OSI) were studied. As a result, VINPO showed positive impact on cardiac functions in the light of electrocardiographic, biochemical and histopathological. According to our results, it is possible to say that it exerts these beneficial effetc via its powerfull antioxidant, antiinflammatory and free radical scavenger effects
Anahtar Kelime:

Konular: Genel ve Dahili Tıp
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Eliot MA, Braunwald E (Çeviri: A.Birand). Akut miyokard infarktüsü. Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (Eds). Harrison İç Hastalıkları Prensipleri’nde. 1. Cilt, 15. Baskı, İstanbul: Nobel Tıp Kitabevi;2004;1383-7.
  • 2. Rona G, Chappel CI, Balazs T, Gaudry R. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. AMA Arch Pathol. 1959;67(4):443-55.
  • 3. Benjamin IJ, Jalil JE, Tan LB, Cho K, Weber KT, Clark WA. Isoproterenolinduced myocardial fibrosis in relation to myocyte necrosis. Circ Res. 1989;65(3):657-70.
  • 4. Sathish S, Ebenezar KK, Devali T. Synergistic effect of nicorandil and amlodipine on tissue defense system during experimental myocardial infarction in rats. Mol Cell Biochem. 2003;243(1-2):133-8.
  • 5. Prince SMP, Karthick M. Preventive effect of rutin on lipids, lipoproteins, and ATPases in normal and isoproterenol-induced myocardial infarction in rats. J Biochem Mol Toxicol. 2007;21(1):1-6.
  • 6. Chattopadhyay A, Biswas S, Bandyopadhyay D, Sarkar C, Datta AG. Effect of isoproterenol on lipid peroxidation and antioxidant enzymes of myocardial tissue of mice and protection by quinidine. Mol Cel Biochem. 2003;245(1-2):43-9.
  • 7. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr. 1993;57(5):715-24.
  • 8. Draper HH, Hadley M. A review of recent studies on the metabolism of exogenous and endogenous malondialdehyde. Xenobiotica. 1990;20(9):901-7.
  • 9. Gök H. Klinik Kardiyoloji. 1. Baskı. İstanbul: Nobel Tıp Kitabevi, 1996;97-171.
  • 10. Becker LB. New consepts in reactive oxygen species and cardiovascular reperfusion physiolog. Cardiovasc Res. 2004;61(3):461-70.
  • 11. Rathore N, John S, Kale M, Bhatnagar D. Lipid peroxidation and antioxidant enzymes in isoproterenol induced oxidative stres in rat tissues. Pharmacol Res. 1998;38(4):297-303.
  • 12. Nath KA, Norby SM. Reactive oxygen species and acute renal failure. Am J Med. 2000; 109(8):665-78.
  • 13. Lei SZ, Pan ZH, Aggarwal SK, Chen HSV, Hartman J, Sucher NJ. Effect of nitric oxide formation on the redox modulatory site of NMDA receptor channel complex. Neuron. 1992;8(6):1087-99.
  • 14. Seigfreid MR, Erhardt J, Rider T, Ma XL, Lefer AM. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischaemia- eperfusion. J Pharmacol Exp Ther. 1992;260(2):668-75.
  • 15. Sreepriya M, Porckodi M, Devaki T, Nayeem M. Anti-oxidant effects of L-¬arginine against isoproterenol-induced myocardial stress in rats. Med Sci Res. 1998;26:587-93
  • 16. Sushamakumari S, Menon VP: Changes in levels of lipid peroxides and activities of superoxide dismutase and catalase in isoproterenol induced myocardial infarction in rats. Ind J Exp Biol. 1987;25(6):419-23.
  • 17. Ferrari R, Ceconi C, Curello S, Cargnoni A, Alfieri O, Pardini A, Marzollo P, Visioli O. Oxygen free radicals and myocardial damage; Protective role of Thiol-containing agents. Am J Med. 1991;91(3):95-105.
  • 18. Agarwal A, Prabakaran SA, Said TM. Prevention of oxidative stress injury to sperm. J Androl. 2005;26(6):654-60.
APA güven t, Sarıhan M, PARLAKPINAR H, VARDI N, Tanbek K (2017). Investigation of the protective and treatment effects of vinpocetine in myocardial infarctional with isoprotenol in rats. , 629 - 634.
Chicago güven taner,Sarıhan Mehmet Ediz,PARLAKPINAR Hakan,VARDI Nigar,Tanbek Kevser Investigation of the protective and treatment effects of vinpocetine in myocardial infarctional with isoprotenol in rats. (2017): 629 - 634.
MLA güven taner,Sarıhan Mehmet Ediz,PARLAKPINAR Hakan,VARDI Nigar,Tanbek Kevser Investigation of the protective and treatment effects of vinpocetine in myocardial infarctional with isoprotenol in rats. , 2017, ss.629 - 634.
AMA güven t,Sarıhan M,PARLAKPINAR H,VARDI N,Tanbek K Investigation of the protective and treatment effects of vinpocetine in myocardial infarctional with isoprotenol in rats. . 2017; 629 - 634.
Vancouver güven t,Sarıhan M,PARLAKPINAR H,VARDI N,Tanbek K Investigation of the protective and treatment effects of vinpocetine in myocardial infarctional with isoprotenol in rats. . 2017; 629 - 634.
IEEE güven t,Sarıhan M,PARLAKPINAR H,VARDI N,Tanbek K "Investigation of the protective and treatment effects of vinpocetine in myocardial infarctional with isoprotenol in rats." , ss.629 - 634, 2017.
ISNAD güven, taner vd. "Investigation of the protective and treatment effects of vinpocetine in myocardial infarctional with isoprotenol in rats". (2017), 629-634.
APA güven t, Sarıhan M, PARLAKPINAR H, VARDI N, Tanbek K (2017). Investigation of the protective and treatment effects of vinpocetine in myocardial infarctional with isoprotenol in rats. Medicine Science, 6(4), 629 - 634.
Chicago güven taner,Sarıhan Mehmet Ediz,PARLAKPINAR Hakan,VARDI Nigar,Tanbek Kevser Investigation of the protective and treatment effects of vinpocetine in myocardial infarctional with isoprotenol in rats. Medicine Science 6, no.4 (2017): 629 - 634.
MLA güven taner,Sarıhan Mehmet Ediz,PARLAKPINAR Hakan,VARDI Nigar,Tanbek Kevser Investigation of the protective and treatment effects of vinpocetine in myocardial infarctional with isoprotenol in rats. Medicine Science, vol.6, no.4, 2017, ss.629 - 634.
AMA güven t,Sarıhan M,PARLAKPINAR H,VARDI N,Tanbek K Investigation of the protective and treatment effects of vinpocetine in myocardial infarctional with isoprotenol in rats. Medicine Science. 2017; 6(4): 629 - 634.
Vancouver güven t,Sarıhan M,PARLAKPINAR H,VARDI N,Tanbek K Investigation of the protective and treatment effects of vinpocetine in myocardial infarctional with isoprotenol in rats. Medicine Science. 2017; 6(4): 629 - 634.
IEEE güven t,Sarıhan M,PARLAKPINAR H,VARDI N,Tanbek K "Investigation of the protective and treatment effects of vinpocetine in myocardial infarctional with isoprotenol in rats." Medicine Science, 6, ss.629 - 634, 2017.
ISNAD güven, taner vd. "Investigation of the protective and treatment effects of vinpocetine in myocardial infarctional with isoprotenol in rats". Medicine Science 6/4 (2017), 629-634.